SBI Securities’s Applied Therapeutics APLT Stock Holding History

SBI Securities’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-788	Closed	-$79	–	4027
2025 Q4	$79	Sell	788 -35	-4%	-$22	﹤0.01%	3475
2025 Q3	$498	Sell	823 -9,978	-92%	-$4.7K	﹤0.01%	2969
2025 Q2	$3.36K	Buy	10,801 +300	+3%	+$116	﹤0.01%	2171
2025 Q1	$5.13K	Buy	10,501 +8,150	+347%	+$4.8K	﹤0.01%	1890
2024 Q4	$2.01K	Buy	+2,351	New	+$14.7K	﹤0.01%	2320

SBI Securities's APLT Position: Q1 2026 in Review

SBI Securities sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 788 shares — an estimated $79 sold.

SBI Securities first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $5.13K in Q1 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

SBI Securities reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 788 Applied Therapeutics shares in Q1 2026, an estimated $79.
SBI Securities first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
SBI Securities's Applied Therapeutics position peaked at $5.13K in Q1 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.